Mekonos became the Silicon Valley Champion in a major Japanese event, the TECH PLAN DEMO DAY conducted by Leave a Nest and sponsored by companies such as Fujikura, Mitsubishi Electric among others. Our team will now head to the 2018 Hyper Interdisciplinary Conference in Tokyo in March and meet major Japanese semiconductor, MEMS and biopharma corporations for potential co-development partnerships and collaborations.
November 11, 2017
Mekonos is at the Skydeck Berkeley Demo Day today as a moonshot startup.
November 9, 2017
Mark will be presenting our technology-in-development and progress at the 4th Annual Medical MEMS and Sensors Conference and Exhibition 2017 at Biltmore Hotel in Santa Clara.
Nov 8-9, 2017
We have been invited by BASELAREA.Swiss, a Swiss Government-funded organization, to participate in the 2017 European Antibody/World Immunotherapy Congress in Basel, Switzerland. Steven is in Basel to be a part of this Congress.
Oct 31-Nov 2, 2017
Steven presented our startup at the 1000 Plan Competition in Suzhou, China at the invitation of the Chinese Government venture arm, Oriza Holdings.
October 12, 2017
Steven has been selected as the first Visiting Scholar as part of the Skydeck, UC Berkeley’s Global Founders Program. He will have a joint appointment with the Sutardja Center of Entrepreneurship & Technology.
October 3, 2017
Mekonos has been selected into the 2017-18 prime cohort of the Creative Destruction Lab-Toronto. The Creative Destruction Lab is a seed-stage program for massively scalable startups commercializing advances in science and technology.
October 1, 2017
We will showcase our technology-in-development at the HYSTA Annual Conference, US-China Tech Investment Summit on October 5 at the Santa Clara Convention Center.
September 29, 2017
We are proud to announce that we have been selected as one of the top 15 companies and invited to the 7th SVIEF meet in Silicon Valley that will be held on Sep 28-29, 2017 with media coverage by CBS, ABC News, CCTV, Tencent and so on. We will have a booth at the Santa Clara Convention Center .
September 14, 2017
Our proposal has been accepted into the renowned Molecular Foundry of the Lawrence Berkeley National Laboratory (LBNL), a US Department of Energy facility. This partnership will allow us to develop our commercially focused chip technology on a small scale at zero cost as part of Mekonos’ user agreement with the LBNL.
August 16, 2017
Mekonos will be presenting her technology-in-development at the 2017 SVIEF Beijing and Shenzhen Convention. We will have a booth at the Beijing International Convention Center. This is being organized by the Silicon Valley Innovation and Entrepreneurship Forum.
July 11-18, 2017
We have been invited to the Hello Tomorrow Global Summit on October 26th & 27th 2017 in Paris, among more than 3,000 projects, as part of Hello Tomorrow’s Top 500 deep-tech startups worldwide, with the support of the French Ministry of Economy. We are proud to have been selected on the American Independence Day!
July 4, 2017
We won the second prize in a major US-China startup event called the 6th 1000 Plan Startup Contest Silicon Valley Regional Competition backed by Oriza Holdings and hosted by SVC Venture Club at the Santa Clara Convention Center.
June 10, 2017
We are proud to announce that Mekonos becomes a part of the prestigious Skydeck at UC Berkeley.
May 1, 2017
Mekonos became the runner-up at the University of California’s elite LAUNCH accelerator program Startup Expo and Demo Day, as the program finally came to an end.
April 27, 2017
Mekonos won the second prize at the Annual “Bear Trap” pitch competition hosted by the Berkeley Entrepreneurs Association, in collaboration with UC Berkeley and the Lawrence Berkeley National Lab.
April 25, 2017
Anil and Steven are presenting some of the results from the bio-prototype development at the Stanford Drug Discovery Conference at the Li Ka Shing Center in Stanford University. They will have a poster.
April 24, 2017
We have been invited to the 9th Precision Medicine World Conference.
January 5, 2017
Mekonos is invited to present at the 9th Annual Biotech Showcase and the 10th Annual OneMedForum and the following conferences during the 35th JP Morgan Healthcare Investor Conference, Jan 9-13, 2017 in San Francisco, California including WuXi Global Forum, Deloitte Leadership Meetings, McDermott Will & Emery Leaders Forum, Breakthroughs in Healthcare Diversity Symposium and 12th Annual Non-Dilutive Funding Summit.
December 25, 2016
Mekonos becomes a California Life Sciences Association Fellow.
December 23, 2016
Phase I bio-prototype experimental setup is completed in collaboration with Anil’s lab at Stanford Center for Genomics and Personalized Medicine and Bianxiao Cui’s Lab at Stanford Chemistry.
December 20, 2016
Anil’s cancer research work at Stanford University gets featured in Cell.
December 15, 2016
Mekonos files for two Australian Provisional Patent applications titled An Array of Needle Manipulators for Biological Cell Injection and Improved Sensing for Automated Biological Cell Injection, with Steven as the primary inventor.
October 31, 2016
First pre-seed investment (at an undisclosed amount) into Mekonos by Dutch Autumn Holding BV. This is in addition to the research grants investment in New Zealand responsible for Steven’s R&D work.
July 16, 2016
Mekonos is officially incorporated in New Zealand.
April 5, 2016
An early prototype of KAREL is presented and nominated for Best Paper Award at the largest interdisciplinary mechanical engineering conference in the world, ASME’s International Mechanical Engineering Congress and Exposition (IMECE) in Montreal, Canada.
November 11, 2014
Before the inception of Mekonos.
June 15, 2014
Copyright (c)2016 Mekonos Limited Inc. All rights reserved.